Literature DB >> 9004132

Variable FMR1 gene methylation of large expansions leads to variable phenotype in three males from one fragile X family.

B B de Vries1, C C Jansen, A A Duits, C Verheij, R Willemsen, J O van Hemel, A M van den Ouweland, M F Niermeijer, B A Oostra, D J Halley.   

Abstract

The fragile X syndrome is caused by an expanded CGG repeat (> 200 units, full mutation) at the 5' end of the FMR1 gene, which is associated with methylation of a CpG island upstream of the FMR1 gene and down regulation of the transcription. We describe three related males with full mutations in the FMR1 gene, as defined by size, but with different percentages of unmethylated alleles (+/-90%, 35%, and 15%, respectively) as studied in leucocytes. Normal mental status was observed in the male who showed 90% lack of methylation, whereas his two cousins were retarded. The mentally normal male did show some minor facial features of the fragile X syndrome; the FMR protein was detectable in 75% of his leucocytes. In all three cases, the proportion of unmethylated FMR1 genes corresponded to the percentage of leucocytes showing FMR1 protein production. Our results indicated a direct relationship between methylation and the ability to produce FMR protein. These cases will be discussed in relation to the phenotypic effects of incompletely methylated full mutations in the FMR1 gene as observed by others.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9004132      PMCID: PMC1050811          DOI: 10.1136/jmg.33.12.1007

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  Translational suppression by trinucleotide repeat expansion at FMR1.

Authors:  Y Feng; F Zhang; L K Lokey; J L Chastain; L Lakkis; D Eberhart; S T Warren
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

2.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.

Authors:  F Rousseau; D Heitz; J Tarleton; J MacPherson; H Malmgren; N Dahl; A Barnicoat; C Mathew; E Mornet; I Tejada
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

3.  Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome.

Authors:  A McConkie-Rosell; A M Lachiewicz; G A Spiridigliozzi; J Tarleton; S Schoenwald; M C Phelan; P Goonewardena; X Ding; W T Brown
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

4.  Normal phenotype in two brothers with a full FMR1 mutation.

Authors:  H J Smeets; A P Smits; C E Verheij; J P Theelen; R Willemsen; I van de Burgt; A T Hoogeveen; J C Oosterwijk; B A Oostra
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

5.  High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression.

Authors:  R J Hagerman; C E Hull; J F Safanda; I Carpenter; L W Staley; R A O'Connor; C Seydel; M M Mazzocco; K Snow; S N Thibodeau
Journal:  Am J Med Genet       Date:  1994-07-15

6.  Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation.

Authors:  F Rousseau; D Heitz; V Biancalana; S Blumenfeld; C Kretz; J Boué; N Tommerup; C Van Der Hagen; C DeLozier-Blanchet; M F Croquette
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

7.  Rapid antibody test for fragile X syndrome.

Authors:  R Willemsen; S Mohkamsing; B de Vries; D Devys; A van den Ouweland; J L Mandel; H Galjaard; B Oostra
Journal:  Lancet       Date:  1995-05-06       Impact factor: 79.321

8.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

9.  DNA methylation represses FMR-1 transcription in fragile X syndrome.

Authors:  J S Sutcliffe; D L Nelson; F Zhang; M Pieretti; C T Caskey; D Saxe; S T Warren
Journal:  Hum Mol Genet       Date:  1992-09       Impact factor: 6.150

10.  No mental retardation in a man with 40% abnormal methylation at the FMR-1 locus and transmission of sperm cell mutations as premutations.

Authors:  F Rousseau; L J Robb; P Rouillard; V M Der Kaloustian
Journal:  Hum Mol Genet       Date:  1994-06       Impact factor: 6.150

View more
  18 in total

Review 1.  Genetic effects on human cognition: lessons from the study of mental retardation syndromes.

Authors:  P Nokelainen; J Flint
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

2.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

Authors:  F Tassone; R J Hagerman; A K Taylor; L W Gane; T E Godfrey; P J Hagerman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.

Authors:  Lorena Santa María; Solange Aliaga; Víctor Faundes; Paulina Morales; Ángela Pugin; Bianca Curotto; Paula Soto; M Ignacia Peña; Isabel Salas; M Angélica Alliende
Journal:  Genet Res (Camb)       Date:  2016-06-28       Impact factor: 1.588

4.  Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats.

Authors:  D Wöhrle; U Salat; D Gläser; J Mücke; M Meisel-Stosiek; D Schindler; W Vogel; P Steinbach
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

Review 5.  The fragile X syndrome.

Authors:  A T Hoogeveen; B A Oostra
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

6.  Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect.

Authors:  R W Burman; P A Yates; L D Green; P B Jacky; M S Turker; B W Popovich
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

7.  Fragile X Syndrome: Scientific Background and Screening Technologies.

Authors:  Justine I Lyons; Gregory R Kerr; Patricia W Mueller
Journal:  J Mol Diagn       Date:  2015-07-07       Impact factor: 5.568

8.  C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.

Authors:  Elaine Y Liu; Jenny Russ; Kathryn Wu; Donald Neal; Eunran Suh; Anna G McNally; David J Irwin; Vivianna M Van Deerlin; Edward B Lee
Journal:  Acta Neuropathol       Date:  2014-05-08       Impact factor: 17.088

9.  The cationic porphyrin TMPyP4 destabilizes the tetraplex form of the fragile X syndrome expanded sequence d(CGG)n.

Authors:  Pnina Weisman-Shomer; Esther Cohen; Inbal Hershco; Samer Khateb; Orit Wolfovitz-Barchad; Laurence H Hurley; Michael Fry
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

10.  Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.

Authors:  Roberta Pietrobono; Maria Grazia Pomponi; Elisabetta Tabolacci; Ben Oostra; Pietro Chiurazzi; Giovanni Neri
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.